The most common hormone other than gastrin, contained in the gastrin-secreting islet cell tumor is –
**Core Concept**
The question is testing the student's knowledge of gastrin-secreting tumors, specifically the types of endocrine tumors that can arise in the pancreas and their associated hormone secretion. Gastrin-secreting islet cell tumors, also known as gastrinomas, are a type of neuroendocrine tumor that can lead to excessive gastrin production, causing peptic ulcers and other gastrointestinal symptoms.
**Why the Correct Answer is Right**
The most common hormone contained in gastrin-secreting islet cell tumors, aside from gastrin, is vasoactive intestinal peptide (VIP). VIPomas are a type of neuroendocrine tumor that secrete excessive amounts of VIP, leading to a clinical syndrome characterized by watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome). This is due to the action of VIP on the intestinal smooth muscle, causing increased secretion of water and electrolytes into the gut lumen. The VIP receptor is a G-protein-coupled receptor that activates adenylyl cyclase, leading to increased cAMP levels and subsequent relaxation of intestinal smooth muscle.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because other hormones, such as insulin, glucagon, and pancreatic polypeptide, are not typically associated with gastrin-secreting tumors. While these hormones can be produced by pancreatic islet cell tumors, they are not the most common hormone contained in gastrinomas.
**Option B:** This option is incorrect because somatostatin is a hormone that actually inhibits gastrin secretion, rather than being produced by gastrin-secreting tumors.
**Option C:** This option is incorrect because calcitonin is a hormone produced by medullary thyroid carcinoma, not gastrin-secreting islet cell tumors.
**Clinical Pearl / High-Yield Fact**
The WDHA syndrome associated with VIPomas is a classic example of a paraneoplastic syndrome, where the symptoms are caused by the effects of excess hormone production, rather than direct tumor invasion or metastasis. This is a high-yield fact for exam purposes, as paraneoplastic syndromes are a common cause of systemic symptoms in patients with neuroendocrine tumors.
**Correct Answer:** C. Vasoactive intestinal peptide (VIP).